BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9614845)

  • 1. Comparison of pentoxifylline, thalidomide and prednisone in the treatment of ENL.
    Moreira AL; Kaplan G; Villahermosa LG; Fajardo TJ; Abalos RM; Cellona RV; Balagon MV; Tan EV; Walsh GP
    Int J Lepr Other Mycobact Dis; 1998 Mar; 66(1):61-5. PubMed ID: 9614845
    [No Abstract]   [Full Text] [Related]  

  • 2. Pentoxifylline in the treatment of erythema nodosum leprosum.
    De Carsalade GY; Achirafi A; Flageul B
    J Dermatol; 2003 Jan; 30(1):64-8. PubMed ID: 12598712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thalidomide in erythema nodosum leprosum (ENL).
    Bourdillon C
    Lepr Rev; 1988 Jun; 59(2):184-5. PubMed ID: 3246930
    [No Abstract]   [Full Text] [Related]  

  • 4. Is pentoxifylline a viable alternative in the treatment of ENL?
    Sarno EN; Nery JA; Garcia CC; Sampaio EP
    Int J Lepr Other Mycobact Dis; 1995 Dec; 63(4):570-1. PubMed ID: 8642222
    [No Abstract]   [Full Text] [Related]  

  • 5. A phase 2 open trial of pentoxifylline for the treatment of leprosy reactions.
    Dawlah ZM; Cabrera A; Ahern K; Levis WR
    Int J Lepr Other Mycobact Dis; 2002 Mar; 70(1):38-43. PubMed ID: 12120041
    [No Abstract]   [Full Text] [Related]  

  • 6. Thalidomide in erythema nodosum leprosum.
    Jew LJ; Middleton RK
    DICP; 1990 May; 24(5):482-3. PubMed ID: 2188435
    [No Abstract]   [Full Text] [Related]  

  • 7. Pentoxifylline may be useful in the treatment of type 2 leprosy reaction.
    Talhari S; Orsi AT; Talhari AC; Souza FH; Ferreira LC
    Lepr Rev; 1995 Sep; 66(3):261-3. PubMed ID: 7500827
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of erythema nodosum leprosum using thalidomide].
    Sheskin J
    Acta Leprol; 1983; 1(1):41-50. PubMed ID: 6401140
    [No Abstract]   [Full Text] [Related]  

  • 9. Pentoxifylline decreases in vivo and in vitro tumour necrosis factor-alpha (TNF-alpha) production in lepromatous leprosy patients with erythema nodosum leprosum (ENL).
    Sampaio EP; Moraes MO; Nery JA; Santos AR; Matos HC; Sarno EN
    Clin Exp Immunol; 1998 Feb; 111(2):300-8. PubMed ID: 9486396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated platelet counts and thrombocytosis in erythema nodosum leprosum.
    Rea TH
    Int J Lepr Other Mycobact Dis; 2002 Sep; 70(3):167-73. PubMed ID: 12483964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thalidomide's effectiveness in erythema nodosum leprosum is associated with a decrease in CD4+ cells in the peripheral blood.
    Shannon EJ; Ejigu M; Haile-Mariam HS; Berhan TY; Tasesse G
    Lepr Rev; 1992 Mar; 63(1):5-11. PubMed ID: 1569817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does pentoxifylline find a place in the armementarium of leprologists in type II reaction?
    Chatterjee M; Jaiswal AK
    Indian J Lepr; 2002; 74(4):329-34. PubMed ID: 12624981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bangkok Workshop on Leprosy Research. Treatment of reactions and nerve damage.
    Naafs B
    Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4 Suppl):S21-8. PubMed ID: 9030120
    [No Abstract]   [Full Text] [Related]  

  • 14. Thalidomide peripheral neuropathy.
    Awofeso N
    Trop Doct; 1992 Jul; 22(3):139-40. PubMed ID: 1322576
    [No Abstract]   [Full Text] [Related]  

  • 15. Decreases in mean hemoglobin and serum albumin values in erythema nodosum leprosum and lepromatous leprosy.
    Rea TH
    Int J Lepr Other Mycobact Dis; 2001 Dec; 69(4):318-27. PubMed ID: 12035293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy of lepromatous erythema nodosum using chloramphenicol. Comparison with thalidomide. Statistical study from the Marchoux Institute].
    Saint-André P; Ferracci C; Baquillon G; Ridel PR; Boucher P
    Acta Leprol; 1981; (84):57-62. PubMed ID: 6797223
    [No Abstract]   [Full Text] [Related]  

  • 17. Thalidomide in lepra reaction (ENL) in lepromatous leprosy patients.
    Chandorkar AG; Burte NP; Jadhav JH; Gade RK; Bulakh PM; Tayshete SN; Kale VM
    Indian J Lepr; 1984; 56(2):264-8. PubMed ID: 6548496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of pentoxifylline in the treatment of type 2 reactional episodes in leprosy.
    Nery JA; Perissé AR; Sales AM; Vieira LM; Souza RV; Sampaio EP; Sarno EN
    Indian J Lepr; 2000; 72(4):457-67. PubMed ID: 11212480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of thalidomide in leprosy.
    Hooper M
    BMJ; 1991 Nov; 303(6814):1404-5. PubMed ID: 1760622
    [No Abstract]   [Full Text] [Related]  

  • 20. The influence of thalidomide on the clinical and immunologic manifestation of erythema nodosum leprosum.
    Sampaio EP; Kaplan G; Miranda A; Nery JA; Miguel CP; Viana SM; Sarno EN
    J Infect Dis; 1993 Aug; 168(2):408-14. PubMed ID: 8335978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.